Coincidental Lung Mass Diagnosis in COVID-19 Infected Patient: A Case Report (original) (raw)
Related papers
Erciyes Medical Journal , 2021
Novel coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). COVID-19 has high mortality rates. It has become a severe pandemic worldwide. Real-time PCR testing is still the gold standard test method for the definitive diagnosis of COVID-19 despite the possibility of false negatives. Radiological imaging methods, especially computed tomography (CT), are important assistant methods in the diagnosis and management of the disease. This review presents the role of CT in COVID-19 pneumonia, its diagnostic accuracy, thorax CT findings of the disease and differential diagnosis.
Imaging Aspects (Chest Radiographic and CT Scan Findings) of COVID-19 with Clinical Classifications
Jordan Journal of Biological Sciences, 2022
Chest radiographic (CXR) and chest computed tomography (CT) scans have been used to diagnose coronavirus (COVID-19) disease as an important counterpart to the reverse transcription polymerase chain reaction (RT-PCR) diagnostic protocol. This work explores the application of CXR and CT scans as diagnostic instruments for COVID-19. Numerous databases were searched from 01/01/2020 till 2020 late for COVID-19 articles which documented the clinical features of CXR and CT scans. The documented cases were based on the evaluation of the imaging characteristics. Chest radiographic findings may be confirmed with the most basic CT scans. Peripheral, bilateral and primary ground-glass distortion are the most prominent CT results with COVID-19 infections. In conclusion, unique and ambiguous terms such as pneumonia, blurred opacities, airspace disease, patchy opacities, and infiltrates make it difficult to perceive the different chest radiographic findings.
Case report A case series of chest imaging manifestation of COVID-19
Radiography, 2020
Coronavirus disease 2019 (COVID-19) is caused by a infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).1It started in Wuhan, China, in December 2019, after which quickly spread tomany other countries around the world. Chest radiography (CXR) and computed tomography (CT) playkey roles in managment and diagnosis of COVID-19. In this case series we are presenting three patientswith predominant left-sided changes caused by COVID-19 infection.
Chest CT Findings in 1048 COVID-19 Patients
Background: The 2019 Coronovirus disease (COVID-19) is a pandemic caused by the novel Severe Acute Respiratory Syndrome coronavirus (SARS nCoV-2). The disease spread rapidly to almost all countries affecting millions of people and killing almost two million people. Computerized Tomography (CT) is an essential imaging tool in diagnosis of the disease. Patterns of lung findings are well reported. This study aims to report on the chest CT findings in confirmed COVID-19 patients in an isolation center in Taif, Saudi Arabia. Methods: Confirmed COVID-19 patients with positive reverse transcriptase polymerase chain reaction (RT-PCR) test, referred for chest CT between June and October 2020 were included in the study. Imaging findings were retrieved and reviewed retrospectively by two radiologists. Findings were tabulated and analyzed using Excel. Results: 1048 patients were included in the study, 68% males. Mean age is 61.1 years (19-105). Initially 23% were not confirmed by RT-PCR test. The commonest findings were ground glass opacities (91%), bilateral multifocal disease (93%), in peripheral distribution (79%), mixed patchy consolidation and ground glass opacities (67%), interlobular septal thickening (43%), consolidation with air bronchogram (39%), pleural thickening (31%), crazy paving (11%), bronchiectasis (7%), pleural effusion (4%) and mediastinal lymphadenopathy and pulmonary embolism (3% each). Conclusion: Chest CT findings in our COVID-19 cohort of patients are similar to those reported in the literature. CT is a sensitive tool for triage and diagnosis in clinically suspected symptomatic COVID-19 patients.
A Review of COVID-19: Data Obtained from Chest CT Imaging and RT-PCR
Iranian Journal of Radiology, 2021
Context: This review aimed to investigate the computed tomography (CT) imaging features of coronavirus disease 2019 (COVID-19). Evidence Acquisition: Bilateral lung involvement (70%), peripheral distribution (67.5%), multifocal involvement (67.3%) and ground glass opacity (66.1%) were observed in most infected patients. Results: Evaluation of the number of lobes involved in infected patients showed no abnormalities in 7.2% (85/1177) of the patients. Regarding the performance of reverse transcription-polymerase chain reaction (RT-PCR) and chest CT scan, the sensitivity of RT-PCR and chest CT imaging was estimated at 70% (925/1311) and 89% (6605/7396) upon admission, respectively; nevertheless, the sensitivity of CT imaging increased as the time from the symptom onset increased. The CT image acquisition parameters affecting image quality and patient dose were also discussed. Studies suggested that these factors should be adjusted according to the disease stage. Based on our findings, ...